Accelerate Diagnosti (AXDX) |
|
12 -0.96 (-7.41%)
|
01-27 06:03 |
|
Open: |
12.91 |
Pre. Close: |
12.96 |
|
High:
|
13.16 |
Low:
|
11.59 |
|
Volume:
|
2,316,429 |
Market Cap:
|
684M |
|
|
|
|
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. It offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
13.174 - 13.25 |
13.25 - 13.318 |
|
Low:
|
11.434 - 11.508 |
11.508 - 11.575 |
|
Close:
|
11.89 - 12.013 |
12.013 - 12.123 |
|
Technical analysis |
as of: 2021-01-26 4:41:20 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 15.37  One year: 17.95 |
| Support: |
Support1: 9.40 Support2: 7.07 |
| Resistance: |
Resistance1: 13.16 Resistance2: 15.37 |
| Pivot: |
9.25 |
| Moving Average: |
MA(5): 10.17 MA(20): 8.83
MA(100): 9.39  MA(250): 11.09 |
| MACD: |
MACD(12,26): 0.73 Signal(9): 0.36 |
| Stochastic oscillator: |
%K(14,3): 81.83 %D(3): 73.45 |
| RSI: |
RSI(14): 72.24 |
| 52-week: |
High: 19.11 Low: 4.53 Change(%): -26.6 |
| Average Vol(K): |
3-Month: 38673 10-Days: 85911 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.AXDX has closed above the upper band by 3.3%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 140% wider than normal. The large width of the bands suggest high volatility as compared to AXDX's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Mon, 25 Jan 2021
Accelerate Diagnostics Inc. (AXDX) Soars 47.61% on January 25 - Equities.com
Mon, 25 Jan 2021
Accelerate Diagnostics Inc (AXDX) Stock: Is It a Good Pick? - InvestorsObserver
Fri, 22 Jan 2021
Accelerate Diagnostics Inc. (AXDX) Soars 3.17% on January 22 - Equities.com
Tue, 19 Jan 2021
Accelerate Diagnostics (NASDAQ:AXDX) Downgraded by Zacks Investment Research to "Hold" - MarketBeat
Mon, 18 Jan 2021
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) to Post Q1 2022 Earnings of ($0.26) Per Share, Piper Sandler Forecasts - MarketBeat
Fri, 15 Jan 2021
Accelerate Diagnostics Inc. (AXDX) Soars 5.13% on January 15 - Equities.com
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Underperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Outperform |
Debt to Equity: |
Underperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. (M) |
57 |
| Shares Float (M) |
27 |
|
% Held by Insiders
|
40.51 |
|
% Held by Institutions
|
52.17 |
|
Shares Short (K)
|
13,740 |
|
Shares Short P. Month (K)
|
14,880 |
Stock Financials |
|
EPS
|
-1.460 |
|
EPS Est This Year
|
-1.200 |
|
EPS Est Next Year
|
-0.980 |
|
Book Value (p.s.)
|
-0.870 |
|
Profit Margin
|
|
|
Operating Margin
|
-580.33 |
|
Return on Assets (ttm)
|
-33.3 |
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
58.0 |
|
Gross Profit (p.s.)
|
0.077 |
|
Sales Per Share
|
0.202 |
|
EBITDA (p.s.)
|
-1.120 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-54 |
|
Levered Free Cash Flow (M)
|
-25 |
Stock Valuations |
|
PE Ratio
|
-8.22 |
|
PEG Ratio
|
|
|
Price to Book value
|
-13.79 |
|
Price to Sales
|
59.35 |
|
Price to Cash Flow
|
-12.69 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
